Trulieve Cannabis ended yesterday at $5.27, a 5.82% increase

Yesterday at a glance: pronounced bullish sentiment in the market helped the medical and recreational cannabis provider to make a notable 5.82% gain yesterday, rising 27 cents and ultimately closing at $5.27.

United States Core PCE Price Index (MoM) (Mar) is next today at 12:30 UTC.

Trulieve Cannabis's uptick comes amid good United States macroeconomic data released during the day — United States Initial Jobless Claims beat the 248,000 projections, with 230,000.

On the flip side, following a previous reading of 0.8%, Pending Home Sales in United States released yesterday at 14:00 UTC fell short of the 0.5% figure expected by analysts with an actual reading of -5.2%. Highly important GDP data from United States beat analyst expectations of two with a reading of 1.1.

Although Trulieve Cannabis Corp. is appreciating today after rising as high as $5.83, price action is now slowing and consolidating around 38 cents below the $5.65 resistance level. Despite posting gains on yesterday, Trulieve Cannabis slid below its 21 day Simple Moving Average at $5.3 during the last session — an early indicator that a negative trend could be emerging.

Trulieve Cannabis is likely to reverse course and start pointing downward in the short term.

A look at other health care stocks also showed bullish price action as Eli Lilly and Company was up 3.74%. Thermo Fisher Scientific traded at $543 after closing yesterday's trading day at $533.13 (up 1.86%).

While Trulieve Cannabis was bullish yesterday, the following health care stocks underperformed: AbbVie closed at $148.87 (down 8%).

Also worthy of note, United States Core PCE Price Index (MoM) (Mar) scheduled to come out today at 12:30 UTC.

11 months ago the leading CBD products developer reached a significant high of $15.16 but has consequently lost 67.15% since then.